Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that the Board of its subsidiary Biocon Biologics Ltd has approved a primary equity investment of US $75 million (Rs. 555 crores) by Abu Dhabi based ADQ, one of the region’s largest holding companies.
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Experts highlighted that robust pharmacopoeial frameworks are essential for maintaining the quality, safety and efficacy of medicines
Move strengthens footprint in Western India and expands multi-specialty care network
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
Subscribe To Our Newsletter & Stay Updated
